Ascendis Pharma Earnings Loss from Eq. Investments (TTM) Analysis

Ascendis Pharma A/S (ASND)

235.40 +6.75 (+2.95%) USD | NASDAQ | Jan 23, 16:00

240.00 +4.60 (+1.95%) After-Hours: 18:58

View Earnings Loss from Eq. Investments (TTM) for ASND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Earnings Loss from Eq. Investments (TTM) Chart

Start Trial

View Historical Data

Start Trial

View Earnings Loss from Eq. Investments (TTM) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Earnings Loss from Eq. Investments (TTM) Benchmarks

Start Trial

Novo Nordisk A/S	--
Evaxion AS	--
DBV Technologies SA	--
Cellectis SA	--
Biodexa Pharmaceuticals Plc	--